Company Filing History:
1 out of 260 
1 out of 7 Years Active: 2021
Title: The Innovative Contributions of Torayuki Okuyama
Introduction: Torayuki Okuyama, a dedicated inventor based in Tokyo, Japan, has made significant strides in medical technology with a focus on treating genetic disorders. With a passion for innovation and a commitment to improving patient outcomes, he has earned recognition in the field of biotechnology.
Latest Patents: Okuyama holds a notable patent for "Methods and compositions for treating Hunter Syndrome." This invention provides essential compositions and methods for the central nervous system (CNS) delivery of Idursulfase-beta, a human recombinant iduronate-2-sulfatase protein. The novel approach outlined in his patent effectively addresses symptoms not only in the brain and spinal cord but also extends to peripheral tissues, including heart, liver, spleen, lung, and kidney, significantly enhancing the therapeutic potential for patients suffering from Hunter Syndrome.
Career Highlights: Throughout his career, Okuyama has worked with prominent companies, including Green Cross Corporation and Medigenebio Corporation. His experience in these organizations has bolstered his expertise in biopharmaceutical development and has facilitated his innovative contributions to the field.
Collaborations: Okuyama has collaborated with talented colleagues such as Thong-Gyu Jin and Han-Yeul Byun. These partnerships reflect a collaborative spirit prevalent in the research community, highlighting the importance of teamwork in driving forward innovative solutions.
Conclusion: Torayuki Okuyama's contributions to the field of biotechnology, particularly in the treatment of Hunter Syndrome, exemplify the impact of dedicated inventors in the medical domain. His innovative methods and compositions are paving the way for more effective treatments, showcasing the crucial role of inventors in advancing healthcare solutions.